Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Danish Osteoporosis Prevention Study
NCT00252408Phase 4Completed
- Sponsor
- Aarhus University
- Start
- Oct 1990
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of estradiol valerate + dydrogesterone in osteoporosis (4 arms), sponsored by Aarhus University. Primary endpoints: Incidence of fractures at 20 years and Bone mineral density at 20 years. Started Oct 1990; status: completed.
02
Drugs
estradiol valerate + dydrogesterone
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00252408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00252408.